Aarkstore Enterprise -the Antipsychotics Market Insight & Analysis 2008

The Antipsychotics Market Insight & Analysis 2008

The total antipsychotics market revenue in 2006 was $18.1bn. predicts that total revenues in the antipsychotics market will peak to $18.6bn by 2007. But what will it be in 2012? This report will tell you.

This in-depth market analysis examines prospects for antipsychotic drugs right through to 2012, including sales forecasts for leading products. The antipsychotics market will face decreasing growth throughout the forecast period, due to the patent expiry of leading blockbuster drugs. Safety concerns over the current antipsychotics along with high prices, will also contribute to decreased growth in this market.

The antipsychotics market currently contains four blockbuster drugs; Zyprexa, Risperdal, Seroquel and Abilify. Visiongain predicts that a fifth drug will also reach blockbuster status by 2008. This detailed report also highlights pipeline developments and important contemporary issues, especially commercial drivers and restraints.

According to the National Alliance for Research on Schizophrenia and Depression, approximately 22.1 per cent of American adults (approximately 64 million people) suffer from a diagnosable mental illness in any given year. Of these, it is estimated that over 2 million suffer from schizophrenia. Similarly, approximately 18.8 million people have a depressive disorder, with approximately 2.3 to 3 million suffering from bipolar disorder.

The Antipsychotic Drugs Market Insight and Analysis 2008 examines the market critically through a comprehensive review of available information. Sources include primary research unavailable elsewhere, in-house and industrial databases, commercial news, published reports, economic research and consultation with experts. applies financial forecasting, qualitative analyses and the assessment of unmet needs to provide a comprehensive market report with detailed analysis and informed opinion.

In particular, The Antipsychotics Market concentrates on the following essential aspects of the market:

Discussion of the current pharmaceutical market

Forecast of the worldwide pharmaceutical market from 2007-2012

Drivers and restraints facing the antipsychotics market

Opportunities and threats facing the antipsychotics market

Growth of the antipsychotic drugs market between 2007-2012

Commercial prospects for the market-leading drugs, with sales forecasts from 2007-2012

The potential of generics manufacturers to penetrate this market

Pipeline developments with blockbuster potential

Currently marketed drugs with blockbuster potential

Discussion of unmet therapeutic needs and relative advantages of products

Why you should buy this report:

To receive a comprehensive analysis of the prospects for antipsychotic drugs from 2007-2012

To discover predicted revenues, growth rates and other key metrics for leading pharmaceutical treatments from 2007-2012

To determine key activities of leading companies

To discover hot pipeline developments and up-and-coming products

To determine the forces that influence the market for antipsychotic products:

Competitive characteristics of the market

Drivers

Restraints

Strengths, weaknesses, opportunities and threats (SWOT analysis)

To find out where the antipsychotics market is heading - both technologically and commercially

The future of current and potential anti-psychotic blockbusters is vitally important to each company. Off label allocation has seen companies write off funds for possible legal actions. Zyprexa-maker Lilly set aside $1.2 billion to settle 31,000 claims and still faces 1,200 cases and a federal probe. Bristol-Myers Squibb, maker of Abilify, agreed to pay $515 million last year, in part to settle off-label marketing allegations; the firms also face thousands of additional claims. AstraZeneca has 8,000 suits pending for Seroquel.

For more information, please contact :

http://www.aarkstore.com/reports/The-Antipsychotics-Market-Insight-Analysis-2008-33073.html

Contact : minu

Aarkstore Enterprise

Tel : +912227453309

Mobile No: +919272852585

Email : contact@aarkstore.com

Website : http://www.aarkstore.com

Blog: http://blogs.aarkstore.com/

by: aarkstore enterprise

POST COMMENT

Will RSS Kill Email Marketing? Tips on Writing an Effective Social Media Marketing Request For Proposal (RFP) Aarkstore Enterprise -respiratory Market Insight 2008- Market Research Aggregator How to Create a Marketing Syllabus and Become a Marketing Rock Star Affiliate Marketing - The Reality Entrepreneur's Coaching Center - A 6 Step Marketing Plan Aarkstore Enterprise -fixed-mobile Convergence Market Analysis 2008- Market Research Aggregator Aarkstore Enterprise -mobile Search 2008-2013: Profiting From Information And Advertising On The Mo Aarkstore Enterprise -the Antibacterial Drug Market Analysis 2008-2013- Market Research Aggregator Economic Indicators - What The Unemployment Report Means To Stock Market Investors Aarkstore Enterprise - Chinese Pharmaceutical Outlook 2008-2023 - Market Research Aggregator Mental vs Physical Activity in Marketing 10 Keys to a Successful Marketing Partnership